港股異動丨影視股走強 影院復工“滿月” 票房大盤再創新高
格隆匯8月17日丨影視股走強,貓眼娛樂漲4.67%,IMAX中國漲逾3%。院復工“滿月”,票房大盤再創新高。在《哈利·波特與魔法石》重映以及《八佰》超前點映的強勢帶動下,上週末三日日均票房均在6000萬級別。截至8月17日零點,影院復工後第四個週末票房累計1.85億。從上週末開始,北上廣等地的電影院獲准將放映廳的上座率從30%提高到50%。中國是世界第二大電影市場,根據中國電影協會發布的最新數據,全國40%的電影院可能因暫時停業而徹底關閉。院線虧損也讓國內電影公司感受到壓力。國內影院7月20日復工後,客流恢復明顯,票房增長強勁。有分析稱,隨着新片陸續上映,國內電影市場有望在10月份恢復正常行情。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.